Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler-Reference-Cited by-同舟云学术

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler

Published:2010-05 Issue:4 Volume:47 Page:447-459
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Berger William E.,Noonan Michael J.

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference67 articles.

1. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma—full report. Bethesda, MD: National Institutes of Health, 2007. NIH Publication Number 08–4051.

2. SYMBICORT® (budesonide/formoterol inhalation aerosol) [prescribing information]. Wilmington, DE: AstraZeneca LP, 2009.

3. Budesonide/Formoterol Pressurized Metered-Dose Inhaler

4. Budesonide/Formoterol

5. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate–Severe Asthma: A Clinical Modelling and Simulation Study;Advances in Therapy;2024-09-06

2. Susceptibility of individuals with lung dysfunction to systemic inflammation associated with ambient fine particle exposure: A panel study in Beijing;Science of The Total Environment;2021-09

3. Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma;Respiratory Medicine;2020-08

4. Susceptibility of individuals with chronic obstructive pulmonary disease to air pollution exposure in Beijing, China: A case-control panel study (COPDB);Science of The Total Environment;2020-05

5. Respiratory Drug/Vaccine Delivery Using Nanoparticles;Mucosal Delivery of Drugs and Biologics in Nanoparticles;2020